Literature DB >> 17076867

Estimating the cost-effectiveness of quality-improving interventions in oral anticoagulation management within general practice.

Neree Claes1, Karen Moeremans, Buntinx Frank, Arnout Jef, Vermylen Jos, Van Loon Herman, Annemans Lieven.   

Abstract

OBJECTIVES: A clinical trial, "Belgian Improvement Study on Oral Anticoagulation Therapy (BISOAT)," significantly improved the quality after implementing four different quality-improving interventions in four randomly divided groups of general practitioners (GPs). The quality-improving interventions consisted of multifaceted education with or without feedback reports on their performance, international normalized ratio (INR) testing by the GP with a CoaguChek device or computer-assisted advice for adapting oral anticoagulation therapy. The quality improvement in INR control versus baseline was similar in the four groups. The aim of the current study was to calculate the cost-effectiveness and influencing factors of the four quality-improving interventions compared with usual care.
METHODS: Activity-based costing techniques with questionnaires were used to determine the global costs per patient per month in the different intervention groups. Effectiveness data were obtained from the BISOAT study. Cost-effectiveness was expressed as cost per additional day within a 0.5 range from INR target.
RESULTS: The one-time cost of multifaceted education was 49,997 euro for the whole study. Monthly continuous costs per intervention ranged between 37 euro and 54 euro per patient. Using the CoaguChek in combination with the multifaceted education was associated with net savings and quality improvement, hence dominated usual care. Sensitivity analyses showed improved cost-effectiveness with extended duration and with increased program size.
CONCLUSION: Implementation of the combination multifaceted education with the use of the CoaguChek is a cost-effective new organizational model of oral anticoagulation management in general practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17076867     DOI: 10.1111/j.1524-4733.2006.00129.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  11 in total

Review 1.  [Portable coagulometer devices in the monitoring and control of oral anticoagulation therapy: a systematic review].

Authors:  Javier Caballero-Villarraso; Román Villegas-Portero; Fernando Rodríguez-Cantalejo
Journal:  Aten Primaria       Date:  2010-10-30       Impact factor: 1.137

Review 2.  The Evidence to Support Point-of-Care Testing.

Authors:  Andrew St John
Journal:  Clin Biochem Rev       Date:  2010-08

Review 3.  Economic Evidence and Point-of-Care Testing.

Authors:  Andrew St John; Christopher P Price
Journal:  Clin Biochem Rev       Date:  2013-08

Review 4.  Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.

Authors:  Danielle E Clarkesmith; Helen M Pattison; Phyo H Khaing; Deirdre A Lane
Journal:  Cochrane Database Syst Rev       Date:  2017-04-05

5.  The cost-effectiveness of point of care testing in a general practice setting: results from a randomised controlled trial.

Authors:  Caroline O Laurence; John R Moss; Nancy E Briggs; Justin J Beilby
Journal:  BMC Health Serv Res       Date:  2010-06-15       Impact factor: 2.655

Review 6.  Computerized clinical decision support systems for therapeutic drug monitoring and dosing: a decision-maker-researcher partnership systematic review.

Authors:  Robby Nieuwlaat; Stuart J Connolly; Jean A Mackay; Lorraine Weise-Kelly; Tamara Navarro; Nancy L Wilczynski; R Brian Haynes
Journal:  Implement Sci       Date:  2011-08-03       Impact factor: 7.327

7.  Centralising and optimising decentralised stroke care systems: a simulation study on short-term costs and effects.

Authors:  Maarten M H Lahr; Durk-Jouke van der Zee; Gert-Jan Luijckx; Patrick C A J Vroomen; Erik Buskens
Journal:  BMC Med Res Methodol       Date:  2017-01-10       Impact factor: 4.615

8.  Economic Evaluation as a Tool in Emerging Technology Assessment.

Authors:  Nataša Bogavac-Stanojević
Journal:  EJIFCC       Date:  2018-11-07

9.  A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - rationale, design and baseline characteristics.

Authors:  Caroline Laurence; Angela Gialamas; Lisa Yelland; Tanya Bubner; Philip Ryan; Kristyn Willson; Briony Glastonbury; Janice Gill; Mark Shephard; Justin Beilby
Journal:  Trials       Date:  2008-08-06       Impact factor: 2.279

10.  Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist.

Authors:  Misericòrdia Carles; Max Brosa; Juan Carlos Souto; Josep Maria Garcia-Alamino; Gordon Guyatt; Pablo Alonso-Coello
Journal:  BMC Health Serv Res       Date:  2015-07-28       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.